William F. Rencher - Oct 19, 2021 Form 3 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Head of CMC and Regulatory
Signature
/s/ Tyler J. Vivian, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Oct 19, 2021
Transactions value $
$0
Form type
3
Date filed
10/19/2021, 06:04 PM
Next filing
Feb 17, 2022
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CNTX Common Stock 1.67K Oct 19, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CNTX Stock Option (right to buy) Oct 19, 2021 Common Stock 12.3K $16.92 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in full 24 months from the date of the grant, April 2, 2020.